Partnership to develop drug against biothreats, infections

February 6, 2014 3:06 AM

19 0

Feb. 5, 2014 at 9:58 PM   |   0 comments

Robin Robinson, director of the Biomedical Advanced Research and Development Authority in the U.S. Department of Health and Human Services, said the authority will support the development of Carbavance under a five-year, cost-sharing agreement with Rempex Pharmaceuticals Inc., a wholly owned subsidi...

Read more

To category page